Estas son algunas de las publicaciones de los investigadores de JM Research.
2014
Nair P, Okhuysen P, Jiang Z, Carlin L, Belkind-Gerson J, Flores J, Paredes-Paredes M and DuPont H. Persistent Abdominal Symptoms in U.S. Adults After Short-term Stay in Mexico. J Travel Med (2014) 21 (3): 153-158
DuPont HL, Petersen A, Zhao J, Mundt A, Jiang ZD, Miller S, Flores J, Shringarpure R, Moro L, Bagin RG, Ballard ED and Totoritis MC. Targeting of Rifamycin SC to the Colon for Treatment of Travelers’ Diarrhoea: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study. J Travel Med 2014 Nov-Dec; 21(6): 369-76
2013
Behrens RH, Cramer JP, Jelinek T, Shaw H, von Sonnenburg F, Wilbraham D, Weinke T, Bell DJ, Asturias E, Pauwells HL, Maxwell R, Paredes-Paredes M, Glenn GM, Dewasthaly S, Stablein DM, Jiang ZD, Dupont HL. Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers’ diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala. Lancet Infect Dis. 2013 Nov 28. pii: S1473-3099(13)70297-4
2011
Paredes-Paredes M, Flores-Figueroa J, Dupont HL. Advances in the treatment of travelers’ diarrhea. Curr Gastroenterol Rep. 2011 Oct;13(5):402-7
Paredes-Paredes M, Okhuysen PC, Flores J, Mohamed JA, Padda RS, Gonzalez-Estrada A, Haley CA, Carlin LG, Nair P, DuPont HL. Seasonality of diarrheagenic Escherichia coli pathotypes in the US students acquiring diarrhea in Mexico. J Travel Med. 2011 Mar-Apr;18(2):121-5.
Flores J, Dupont HL, Jiang ZD, Okhuysen PC, Melendez-Romero JH, Gonzalez-Estrada A, Carrillo I, Paredes M. A randomized, double-blind, pilot study of rifaximin 550 mg versus placebo in the prevention of travelers’ diarrhea in Mexico during the dry season. J Travel Med. 2011 Sep-Oct;18(5):333-6.
NA, Okhuysen PC, Flores-Figueroa J, Jiang ZD, Belkind-Gerson J, Paredes M, Mohamed JA, Nair P, Carlin L, DuPont HL. Campylobacter jejuni is not an important pathogen as a cause of diarrhea in US travelers to Mexico. J Travel Med. 2011 Jan-Feb;18(1):56-8.
Flores-Figueroa J, Okhuysen PC, von Sonnenburg F, DuPont HL, Libman MD, Keystone JS, Hale DC, Burchard G, Han PV, Wilder-Smith A, Freedman DO for the GeoSentinelSurvbeillance Network. Patterns of Illness in Travelers Visiting Mexico and Central America: the GeoSentinel Experience. Clin Infect Dis 2011; 53: 523-31
Mohamed JA, DuPont HL, Flores J, Palur H, Nair P, Jiang ZD, Guo D, Belkind-Gerson J and Okhuysen PC. Single nucleotide polymorphisms in the promoter of the gene encoding the lipopolysaccharide receptor CD14 are associated with and increased risk for bacterial diarrhea in North American travelers to Mexico. Clin Infect Dis 2011; 52: 1332-41.
2009
Flores J and Okhuysen PC. Enteroaggregative Escherichia coli Infection. CurrOpinGastroenterol 2009; 25: 8-11
Mohamed JA, Dupont HL, Jiang ZD, Flores J, Carlin LG, Belkind-Gerson J, Martinez-Sandoval FG, Guo D, White Jr AC and Okhuysen PC. A Single-Nucleotide Polymorphism in the Gene Encoding Osteoprotegerin, an Anti-inflammatory Protein Produced in Response to Infection with DiarrheagenicEscherichia coli, Is Associated with an Increased Risk of Nonsecretory Bacterial Diarrhea in North American Travelers to Mexico. J Infect Dis 2009; 199: 477-85.
Flores J and Okhuysen PC. Genetics of Susceptibility to Infection with Enteric Pathogens. CurrOpin Infect Dis 2009; 22: 471-6.
2008
Flores J, DuPont HL, Lee SA, Belkind-Gerson J, Paredes M, Mohamed JA, Armitige LY, Guo DC, Okhuysen PC. Influence of host interleukin-10 polymorphisms on development of traveler’s diarrhea due to heat-labile enterotoxin-producing Escherichia coli in travelers from the United States who are visiting Mexico. Clin Vaccine Immunol. 2008 Aug;15(8):1194-8.
Flores J, DuPont HL, Jiang ZD, Belkind-Gerson J, Mohamed JA, Carlin LG, PaddaRS, Paredes M, Martinez-Sandoval JF, Villa NA, Okhuysen PC. Enterotoxigenic Escherichia coli heat-labile toxin seroconversion in US travelers to Mexico. J Travel Med. 2008 May-Jun;15(3):156-61.
Nair P, Mohamed JA, DuPont HL, Figueroa JF, Carlin LG, Jiang ZD, Belkind-Gerson J, Martinez- Sandoval FG and Okhuysen PC. Epidemiology of Cryptosporidiosis in North American travelers to Mexico. Am J Trop Med Hyg 2008; 72: 210-4.
Grimes KA, Mohamed JA, DuPont HL, Padda RS, Jiang ZD, Flores J, Belkind-Gerson J, Martinez- Sandoval FG and Okhuysen PC. A PCR Based Assay for the Detection of Diarrheagenic Escherichia coli from Occult Blood Detection Cards in U.S. Travelers to Mexico with Acute Diarrhea. J ClinMicrobiol 2008; 46: 2227-30.
BH, Kazempour K, Breisch SA and Glenn GM. Protection against Travelers’ Diarrhea in a Randomized, Double-blind, Placebo- Controlled Field Trial of a Patch Containing Heat-Labile Toxin from Escherichia coli. Lancet 2008; 371:2019-2025.
Huang DB, Brown EL, DuPont HL, Cerf J, Carlin L, Flores J, Belkind-Gerson J, Nataro JP and Okhuysen PC. Seroprevalence to the enteroaggregative Escherichia coli virulence factor dispersin among USA travelers to Cuernavaca, Mexico: A Pilot Study. J Med Microbiol.2008; 57: 476-9.
2007
Ouyang-Latimer J, Ajami NJ, Jiang ZD, Okhuysen PC, Paredes M, Flores J, Dupont HL. Biochemical and genetic diversity of enterotoxigenic Escherichia coli associated with diarrhea in United States students in Cuernavaca and Guadalajara, Mexico, 2004-2007. J Infect Dis. 2010 Jun 15;201(12):1831-8.
Mohamed JA, DuPont HL, Jiang ZD, Belkind-Gerson J, Figueroa JF, Armitige LY, Tsai A, Nair P, Martinez-Sandoval FJ, Guo D, Hayes P and Okhuysen PC. A Novel Single Nucleotide Polymorphism in the Lactoferrin Gene Is Associated with Susceptibility to Diarrhea in North American Travelers to Mexico. Clin Infect Dis 2007; 44: 945-52.